These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7510716)

  • 41. Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus.
    Kristjansdottir H; Steinsson K; Gunnarsson I; Gröndal G; Erlendsson K; Alarcón-Riquelme ME
    Arthritis Rheum; 2010 Jun; 62(6):1702-11. PubMed ID: 20178125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
    Cabrera CM; Urra JM; Carreño A; Zamorano J
    Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Studies on Fas ligand expression in patients with systemic lupus erythematosus].
    Feng Y
    Hokkaido Igaku Zasshi; 1997 Jul; 72(4):443-55. PubMed ID: 9266252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
    Daniel PT; Krammer PH
    J Immunol; 1994 Jun; 152(12):5624-32. PubMed ID: 7515909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M; Raziuddin S
    J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell Survival Failure in Effector T Cells From Patients With Systemic Lupus Erythematosus Following Insufficient Up-Regulation of Cold-Shock Y-Box Binding Protein 1.
    Meltendorf S; Fu H; Pierau M; Lindquist JA; Finzel S; Mertens PR; Gieseler-Halbach S; Ambach A; Thomas U; Lingel H; Voll RE; Brunner-Weinzierl MC
    Arthritis Rheumatol; 2020 Oct; 72(10):1721-1733. PubMed ID: 32475063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-1) in active lupus.
    Silvestris F; Grinello D; Tucci M; Cafforio P; Dammacco F
    Lupus; 2003; 12(1):8-14. PubMed ID: 12587820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
    Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
    J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
    Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
    Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.
    Weller M; Frei K; Groscurth P; Krammer PH; Yonekawa Y; Fontana A
    J Clin Invest; 1994 Sep; 94(3):954-64. PubMed ID: 7521890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fas/APO-1 expression and function on malignant cells of hematologic and nonhematologic origin.
    Owen-Schaub LB; Meterissian S; Ford RJ
    J Immunother Emphasis Tumor Immunol; 1993 Oct; 14(3):234-41. PubMed ID: 7507710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of dexamethasone on the expression of Fas molecules and apoptosis of lymphocytes in patients with systemic lupus erythematosus.
    Ho CY; Wong CK; Li EK; Lam WK
    Immunol Invest; 2001 Aug; 30(3):231-43. PubMed ID: 11570643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of radix Astragali injection on apoptosis of lymphocytes and immune function in patients with systemic lupus erythematosus].
    Cai XY; Xu YL; Lin XJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 May; 26(5):443-5. PubMed ID: 16883914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigen density on the surface of mononuclear cells in SLE.
    Szegedi G; Surányi P; Damjanovich S
    Immunol Lett; 1987 Jul; 15(3):243-7. PubMed ID: 3311977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum elevations of soluble Fas (CD95/apo-I) concur in deregulating T cell apoptosis during active lupus disease.
    Silvestris F; Williams RC; Calvani N; Grinello D; Tucci M; Cafforio P; Dammacco F
    Clin Exp Med; 2002 May; 2(1):13-27. PubMed ID: 12049185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: a review.
    Rose LM; Latchman DS; Isenberg DA
    Br J Rheumatol; 1997 Feb; 36(2):158-63. PubMed ID: 9133921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases.
    Singh R; Pradhan V; Patwardhan M; Ghosh K
    Indian J Hum Genet; 2009 Sep; 15(3):98-102. PubMed ID: 21088713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.